Streetbeat News

Price Targets

ROST

Gordon Haskett analyst Chuck Grom has upgraded Ross Stores (NASDAQ:ROST) from Accumulate to Buy and announced a $135 price target.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:16 pm

FUN

Citigroup analyst James Hardiman has upgraded Cedar Fair (NYSE:FUN) from Neutral to Buy and raised the price target from $40 to $46.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:13 pm

ACAD

Morgan Stanley analyst Jeffrey Hung has maintained an Equal-Weight rating on ACADIA Pharmaceuticals (NASDAQ:ACAD) and raised the price target from $30 to $31.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:12 pm

FHN

Wedbush analyst David Chiaverini has upgraded First Horizon (NYSE:FHN) from Neutral to Outperform and raised the price target from $12 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:11 pm

COHU

CYBR

EL

FTNT

INMD

MRNA

OTLK

PZZA

SQ

SWKS

Several Wall Street analysts have updated their outlooks on various stocks. Keybanc cut Skyworks Solutions' price target from $130 to $120 and increased Cyberark Software's price target from $196 to $210. Needham lowered Cohu's price target from $52 to $42. HC Wainwright & Co. raised Outlook Therapeutics' price target from $1 to $2. UBS cut Inmode's price target from $52 to $24. Evercore ISI Group slashed Fortinet's price target from $78 to $51. Stifel cut Papa John's price target from $81 to $65. Berenberg lowered Estee Lauder's price target from $224 to $118. Canaccord Genuity cut Block's price target from $90 to $80. HSBC cut Moderna's price target from $89 to $69.

Portfolio Pulse from Lisa Levin

November 03, 2023 | 12:11 pm

EWBC

Wedbush analyst David Chiaverini has upgraded East West Bancorp (NASDAQ:EWBC) from Neutral to Outperform and raised the price target from $57 to $69.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:10 pm

KYMR

HC Wainwright & Co. analyst Andrew Fein maintains a 'Buy' rating on Kymera Therapeutics (NASDAQ:KYMR), but has lowered the price target from $85 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:05 pm

OMCL

Wells Fargo analyst Stan Berenshteyn has upgraded Omnicell (NASDAQ:OMCL) from Underweight to Equal-Weight and lowered the price target from $39 to $28.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:04 pm

TAP

Deutsche Bank analyst Steve Powers has upgraded Molson Coors Beverage (NYSE:TAP) from Sell to Hold and raised the price target from $57 to $58.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:02 pm

CRUS

Over the past 3 months, 4 analysts have published their opinion on Cirrus Logic (NASDAQ:CRUS) stock. The average price target for the stock is $97.5, with a high of $110.00 and a low of $80.00. The average price target has increased by 1.56% over the past month.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 12:00 pm